Dr. E. Gabriela Chiorean

For the Media

Dr. E. Gabriela Chiorean

Dr. Gabriela Chiorean is an associate member of Fred Hutch's Clinical Research Division. She conducts translational research on gastrointestinal and pancreatic cancers. She specializes in treating patients with colorectal, gastrointestinal, hepatobiliary and pancreatic cancer.

Resources for more information

Overview of Gabriela Chiorean's clinical/research focus 
She is an associate professor of Medicine at the University of Washington School of Medicine, Chiorean is an expert in treating colorectal, gastrointestinal, hepatobiliary, and pancreatic cancers. She also conducts Phase I clinical studies, searching for the best treatments for hard-to-treat diseases.

Gabriela Chiorean - Curriculum Vitae

Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.



Download photos of Dr. E. Gabriela Chiorean.

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.